HEMORHEOLOGICAL EFFECTS OF A 5-HT2 RECEPTOR ANTAGONIST (KETANSERIN) IN PATIENTS WITH LEG ISCHEMIA

被引：0
|
作者：
BOGAR, L
WALKER, RT
FLUTE, PT
DORMANDY, JA
机构：
[1] ST GEORGES HOSP,DEPT HAEMATOL & SURG,LONDON,ENGLAND
[2] ST JAMES HOSP,LONDON SW12 8HW,ENGLAND
来源：
THROMBOSIS AND HAEMOSTASIS | 1985年 / 54卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：23 / 23
页数：1
相关论文
共 50 条
  • [21] VASCULAR EFFECTS OF KETANSERIN (R-41-468), A NOVEL ANTAGONIST OF 5-HT2 SEROTONERGIC RECEPTORS
    VANNUETEN, JM
    JANSSEN, PAJ
    VANBEEK, J
    XHONNEUX, R
    VERBEUREN, TJ
    VANHOUTTE, PM
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1981, 218 (01): : 217 - 230
  • [22] Psychological and physiological effects of MDMA ("ecstasy") after pretreatment with the 5-HT2 antagonist ketanserin in healthy humans
    Liechti, ME
    Saur, MR
    Gamma, A
    Hell, D
    Vollenweider, FX
    NEUROPSYCHOPHARMACOLOGY, 2000, 23 (04) : 396 - 404
  • [23] KETANSERIN IN HYPERTENSION - EARLY CLINICAL-EVALUATION AND DOSE FINDING STUDY OF A NEW 5-HT2 RECEPTOR ANTAGONIST
    ANDREN, L
    SVENSSON, A
    DAHLOF, B
    EGGERTSEN, R
    HANSSON, L
    ACTA MEDICA SCANDINAVICA, 1983, 214 (02): : 125 - 130
  • [24] EFFECTS OF KETANSERIN, A SELECTIVE 5-HT2 SEROTONERGIC ANTAGONIST, ON THE SECONDARY RECRUITMENT OF HUMAN-PLATELETS INVITRO
    DECLERCK, F
    XHONNEUX, B
    AGENTS AND ACTIONS, 1986, 17 (5-6): : 515 - 526
  • [25] EFFECT OF THE 5-HT2 ANTAGONIST KETANSERIN ON THE ECT-INDUCED PROLACTIN-RELEASE
    ZIS, AP
    MANJI, HK
    REMICK, RA
    GRANT, BEK
    CLARK, CM
    BIOLOGICAL PSYCHIATRY, 1989, 26 (01) : 102 - 106
  • [26] EFFECTS OF 5-HT2 RECEPTOR ANTAGONIST ON CYCLOHEXIMIDE-INDUCED AMNESIA IN MICE
    NABESHIMA, T
    ITOH, K
    KAWASHIMA, K
    KAMEYAMA, T
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1989, 32 (03) : 787 - 790
  • [27] EFFECTS OF AMPEROZIDE IN SCHIZOPHRENIA - AN OPEN STUDY OF A POTENT 5-HT2 RECEPTOR ANTAGONIST
    AXELSSON, R
    NILSSON, A
    CHRISTENSSON, E
    BJORK, A
    PSYCHOPHARMACOLOGY, 1991, 104 (03) : 287 - 292
  • [28] INVIVO PHARMACOLOGY OF IRINDALONE, A 5-HT2 RECEPTOR ANTAGONIST WITH PREDOMINANT PERIPHERAL EFFECTS
    ARNT, J
    BOGESO, KP
    BOECK, V
    CHRISTENSEN, AV
    DRAGSTED, N
    HYTTEL, J
    SKARSFELDT, T
    DRUG DEVELOPMENT RESEARCH, 1989, 16 (01) : 59 - 70
  • [29] 5-HT2 receptor antagonist improves vasomotor responses in patients with PAOD and CAD
    Tretjakovs, P
    Kalnins, U
    Jurka, A
    Cepurite, L
    Stifts, A
    Pirags, V
    ATHEROSCLEROSIS SUPPLEMENTS, 2004, 5 (01) : 154 - 154
  • [30] THE CA-2+ CHANNEL AND 5-HT2 RECEPTOR ANTAGONIST (S)-EMOPAMIL IN CEREBRAL-ISCHEMIA
    DEFEUDIS, FV
    TRENDS IN PHARMACOLOGICAL SCIENCES, 1989, 10 (06) : 215 - 217
12345